Where does Taiko Pharmaceutical Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Taiko Pharmaceutical Co., Ltd. ranks #23,498 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Taiko Pharmaceutical Co., Ltd. hold?

Taiko Pharmaceutical Co., Ltd. holds 12 US utility patents granted between 2015 and 2023, spanning 10 technology areas.

What is Taiko Pharmaceutical Co., Ltd.'s Innovation Score?

Taiko Pharmaceutical Co., Ltd. has an Innovation Score of 31.9 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Taiko Pharmaceutical Co., Ltd.'s patent grant rate increasing or decreasing?

Taiko Pharmaceutical Co., Ltd.'s recent grant velocity is -67% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Taiko Pharmaceutical Co., Ltd.'s patents?

Taiko Pharmaceutical Co., Ltd.'s patents average 8.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Taiko Pharmaceutical Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Taiko Pharmaceutical Co., Ltd.

Q: What technology areas does Taiko Pharmaceutical Co., Ltd. focus on?

Taiko Pharmaceutical Co., Ltd.'s top technology area is C01B (Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c) with 6 patents, ranking #384 of 1,689 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 12 granted patents across 10 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C01B (Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Taiko ranks #23,498 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 10 technology areas.

#23,498
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.9/100): 8.7
avg claims per patent: -67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23498 · Foreign Corporation #23,498 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,498/49,997
PHOTO-FINISH Symbolic
CPC-FOCUS C01B · 10 areas
INNOV-THIN 31.9/100
CLAIMS-PAR 8.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Symbolic LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Taiko’s 31.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (28%) Velocity 6.7 pts (21%) Breadth 11.2 pts (35%) Claim depth 5.2 pts (16%)

Qualcomm Incorporated · highest

85
Taiko Pharmaceutical · this assignee

32
3D Lighting… · lowest

7

What this shows Taiko's Innovation Score is 31.9/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Taiko?

Each dot is one of Taiko’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Taiko’s own 8.7 claims/patent is at or below the 12.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Taiko vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Taiko's grants concentrate

Taiko Pharmaceutical Co., Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 50% of grants classified under C01B (Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2015. By volume, Taiko sits between Symbolic LLC and TBK Co., Ltd..

Taiko's three-year grant acceleration

Taiko Pharmaceutical Co., Ltd. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Symbolic

12
Symphogen A/S

12
Synecor

12
Synthomer Adhesive

12
Taiwan Alpha

12
Taiwan Main Ortho…

12
TAK Logic

12
TBK

12
Taiko Pharmaceuti… ◀

12

What this shows Taiko holds 12 patents at rank #23,488, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Taiko

By rank, the assignees closest to #23,488 in granted patent volume.

Leaders in C01B (Non-metallic Elements)

Other assignees with the most granted patents in Taiko's primary technology class.

Taiko's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Taiko Pharmaceutical Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	8.3%
2016	2	16.7%
2017	3	25.0%
2018	2	16.7%
2019	1	8.3%
2020	1	8.3%
2022	1	8.3%
2023	1	8.3%

Which technologies does Taiko Pharmaceutical Co., Ltd. patent most?

C01B - Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c 6

C25B - Electrolytic OR Electrophoretic Processes FOR THE Production OF Compounds OR NON-METALS; Apparatus Therefor 4

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

A62B - Devices, Apparatus OR Methods FOR Life-saving 3

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Y10T - Technical Subjects Covered BY Former US Classification 1

B01D - Separation 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Taiko Pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.

Taiko Pharmaceutical Co., Ltd.'s lead technology class is C01B (Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c), 50% of its portfolio - see every assignee active in that class. Explore C01B
Ranked #23,498 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Taiko Pharmaceutical Co., Ltd. against Symbolic LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.